Business plan & valuation

Drugs2Market can assess business plans for product launches or relaunches.
Our experts can shape, help focus or critically assess valuations proposed by teams on strategic direction.

Drugs2Market can quantify revenue targets, assess required operating costs (OPEX), and structure all assumptions within a comprehensive business plan supported by a timeline and key milestones.